{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:15:19Z","timestamp":1785842119602,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,3,9]],"date-time":"2004-03-09T00:00:00Z","timestamp":1078790400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1038\/sj.bjc.6601715","type":"journal-article","created":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T17:14:03Z","timestamp":1080666843000},"page":"1386-1391","source":"Crossref","is-referenced-by-count":58,"title":["Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian\u2013Swedish Women's Lifestyle and Health Cohort Study"],"prefix":"10.1038","volume":"90","author":[{"given":"M","family":"Kumle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Weiderpass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Braaten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-O","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,9]]},"reference":[{"key":"BF6601715_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/oxfordjournals.aje.a115679","volume":"132","author":"HO Adami","year":"1990","unstructured":"Adami HO, Bergstrom R, Persson I, Sparen P (1990) The incidence of ovarian cancer in Sweden, 1960\u20131984. Am J Epidemiol 132: 446\u2013452","journal-title":"Am J Epidemiol"},{"key":"BF6601715_CR2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(88)90869-0","volume":"2","author":"V Beral","year":"1988","unstructured":"Beral V, Hannaford P, Kay C (1988) Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study. Lancet 2: 1331\u20131335","journal-title":"Lancet"},{"key":"BF6601715_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bmj.318.7176.96","volume":"318","author":"V Beral","year":"1999","unstructured":"Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G (1999) Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46\u2009000 women from Royal College of General Practitioners' oral contraception study. BMJ 318: 96\u2013100","journal-title":"BMJ"},{"key":"BF6601715_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<780::AID-IJC15>3.0.CO;2-C","volume":"71","author":"T Bjorge","year":"1997","unstructured":"Bjorge T, Engeland A, Hansen S, Trope CG (1997) Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954\u20131993. Int J Cancer 71: 780\u2013786","journal-title":"Int J Cancer"},{"key":"BF6601715_CR5","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control Cancer Steroid Hormone Study (1987) The reduction in risk of ovarian cancer associated with oral-contraceptive use. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. N Engl J Med 316: 650\u2013655","DOI":"10.1056\/NEJM198703123161102"},{"key":"BF6601715_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0010-7824(86)90079-X","volume":"33","author":"A Coulter","year":"1986","unstructured":"Coulter A, Vessey MP, McPherson K, Crossley B (1986) The ability of women to recall their oral contraceptive histories. Contraception 33: 127\u2013137","journal-title":"Contraception"},{"key":"BF6601715_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables. J Roy Statist Soc Series B 34: 187\u2013220","journal-title":"J Roy Statist Soc Series B"},{"key":"BF6601715_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijc.2910490112","volume":"49","author":"S Franceschi","year":"1991","unstructured":"Franceschi S, Parazzini F, Negri E, Booth M, La Vecchia C, Beral V, Tzonou A, Trichopoulos D (1991) Pooled analysis of 3 European case\u2013control studies of epithelial ovarian cancer: III. Oral contraceptive use. Int J Cancer 49: 61\u201365","journal-title":"Int J Cancer"},{"key":"BF6601715_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/1097-0142(19950715)76:2<284::AID-CNCR2820760219>3.0.CO;2-5","volume":"76","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE, Colditz GA, Hunter DJ, Willett WC, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE (1995) A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer 76: 284\u2013290","journal-title":"Cancer"},{"key":"BF6601715_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0010-7824(97)00172-8","volume":"56","author":"DJ Hunter","year":"1997","unstructured":"Hunter DJ, Manson JE, Colditz GA, Chasan-Taber L, Troy L, Stampfer MJ, Speizer FE, Willett WC (1997) Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women. Contraception 56: 373\u2013378","journal-title":"Contraception"},{"key":"BF6601715_CR11","unstructured":"IARC Working Group (1999) Volume 72. Hormonal Contraception and Post-Menopausal Hormonal Therapy. Lyon: World Health Organization, International Agency for Research on Cancer"},{"key":"BF6601715_CR12","first-page":"1375","volume":"11","author":"M Kumle","year":"2002","unstructured":"Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E (2002) Use of oral contraceptives and breast cancer risk: The Norwegian\u2013Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 11: 1375\u20131381","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6601715_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00008469-199908000-00005","volume":"8","author":"C La Vecchia","year":"1999","unstructured":"La Vecchia C, Franceschi S (1999) Oral contraceptives and ovarian cancer. Eur J Cancer Prev 8: 297\u2013304","journal-title":"Eur J Cancer Prev"},{"key":"BF6601715_CR14","first-page":"11","volume-title":"Incidence of Cancer in Norway, 1978","author":"E Lund","year":"1981","unstructured":"Lund E (1981) Pilot Study for the Evaluation of Completeness of Reporting to the Cancer Registry. In Incidence of Cancer in Norway, 1978, pp 11\u201314. Oslo: The Cancer Registry of Norway"},{"key":"BF6601715_CR15","first-page":"1","volume":"2","author":"AS Lunde","year":"1980","unstructured":"Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J (1980) The person-number systems of Sweden, Norway, Denmark, and Israel. Vital Health Stat 2 2: 1\u201359","journal-title":"Vital Health Stat 2"},{"key":"BF6601715_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/02841868409136026","volume":"23","author":"B Mattsson","year":"1984","unstructured":"Mattsson B, Wallgren A (1984) Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23: 305\u2013313","journal-title":"Acta Radiol Oncol"},{"key":"BF6601715_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/oxfordjournals.aje.a116907","volume":"138","author":"P Nischan","year":"1993","unstructured":"Nischan P, Ebeling K, Thomas DB, Hirsch U (1993) Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol 138: 697\u2013703","journal-title":"Am J Epidemiol"},{"key":"BF6601715_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0959-8049(99)00313-5","volume":"36","author":"F Parazzini","year":"2000","unstructured":"Parazzini F, Chatenoud L, Chiantera V, Benzi G, Surace M, La Vecchia C (2000) Population attributable risk for ovarian cancer. Eur J Cancer 36: 520\u2013524","journal-title":"Eur J Cancer"},{"key":"BF6601715_CR19","first-page":"345","volume":"25","author":"S Ramcharan","year":"1980","unstructured":"Ramcharan S, Pellegrin FA, Ray RM, Hsu JP (1980) The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: a comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives. J Reprod Med 25: 345\u2013372","journal-title":"J Reprod Med"},{"key":"BF6601715_CR20","first-page":"1","volume-title":"An Epidemiologic Study of Epithelial Ovarian Malignancies: With Focus on Hormone-related Factors","author":"T Riman","year":"2003","unstructured":"Riman T (2003) An Epidemiologic Study of Epithelial Ovarian Malignancies: With Focus on Hormone-related Factors, pp 1\u201366. Stockholm, Sweden: Department of Medical Epidemiology, Karolinska Institutet"},{"key":"BF6601715_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00001648-200003000-00005","volume":"11","author":"V Siskind","year":"2000","unstructured":"Siskind V, Green A, Bain C, Purdie DM (2000) Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology 11: 106\u2013110","journal-title":"Epidemiology"},{"key":"BF6601715_CR22","doi-asserted-by":"crossref","unstructured":"The WHO Collaborative Study of Neoplasia and Steroid Contraceptives (1989) Epithelial ovarian cancer and combined oral contraceptives. Int J Epidemiol 18: 538\u2013545","DOI":"10.1093\/ije\/18.3.538"},{"key":"BF6601715_CR23","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1136\/bmj.294.6586.1518","volume":"294","author":"M Vessey","year":"1987","unstructured":"Vessey M, Metcalfe A, Wells C, McPherson K, Westhoff C, Yeates D (1987) Ovarian neoplasms, functional ovarian cysts, and oral contraceptives. Br Med J (Clin Res Ed) 294: 1518\u20131520","journal-title":"Br Med J (Clin Res Ed)"},{"key":"BF6601715_CR24","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/bjc.1995.260","volume":"71","author":"M Vessey","year":"1995","unstructured":"Vessey M, Painter R (1995) Endometrial and ovarian cancer and oral contraceptives \u2013 findings in a large cohort study. Br J Cancer 71: 1340\u20131342","journal-title":"Br J Cancer"},{"key":"BF6601715_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1067\/mob.2002.118657","volume":"186","author":"GR Walker","year":"2002","unstructured":"Walker GR, Schlesselman JJ, Ness RB (2002) Family history of cancer, oral contraceptive use, and ovarian cancer risk. Am J Obstet Gynecol 186: 8\u201314","journal-title":"Am J Obstet Gynecol"},{"key":"BF6601715_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ijc.2910280602","volume":"28","author":"NS Weiss","year":"1981","unstructured":"Weiss NS, Lyon JL, Liff JM, Vollmer WM, Daling JR (1981) Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer 28: 669\u2013671","journal-title":"Int J Cancer"},{"key":"BF6601715_CR27","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case\u2013control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136: 1184\u20131203","journal-title":"Am J Epidemiol"},{"key":"BF6601715_CR28","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/1097-0142(19811001)48:7<1684::AID-CNCR2820480735>3.0.CO;2-A","volume":"48","author":"WC Willett","year":"1981","unstructured":"Willett WC, Bain C, Hennekens CH, Rosner B, Speizer FE (1981) Oral contraceptives and risk of ovarian cancer. Cancer 48: 1684\u20131687","journal-title":"Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601715","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T18:25:38Z","timestamp":1734287138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,9]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["BF6601715"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601715","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,9]]}}}